14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
TMO vs LZAGY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Thermo Fisher Scientific, Inc. (TMO) is the stronger overall head-to-head candidate over LZAGY (LZAGY) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TMO carries a Unified Composite Score of 51.5/100 (HOLD) at $669.54 (24.1x Forward P/E, 19.1% operating margin), whereas LZAGY carries 44.5/100 (HOLD) at $77.10 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TMO vs LZAGY. Trailing 12-month operating profitability (TMO 19.1% vs LZAGY N/A) and valuation multiples (TMO 24.1x vs LZAGY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ TMO vs LZAGY Key Questions & Quantitative Answers
As of Nov 20, 2026, Thermo Fisher Scientific, Inc. (TMO) is the stronger overall head-to-head candidate over LZAGY (LZAGY) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TMO carries a Unified Composite Score of 51.5/100 (HOLD) at $669.54 (24.1x Forward P/E, 19.1% operating margin), whereas LZAGY carries 44.5/100 (HOLD) at $77.10 (N/M Forward P/E, N/A operating margin). Technically, TMO sits in a Neutral phase (RSI 43.0, CONSOLIDATION options structure) and LZAGY sits in a Neutral phase (RSI 48.7, UNCLASSIFIED options structure).
TMO leads the Growth & Scale pillar: TMO posts +9.1% YoY revenue growth and +8.7% YoY earnings growth on $47.4B TTM revenue (41.3% gross margin, 19.1% operating margin), compared with LZAGY at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, TMO generates $47.4B in USD-normalized revenue versus N/A for LZAGY. In operating R&D and SG&A reinvestment, TMO deploys 22.2% of Rev ($10.5B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LZAGY.
TMO screens cheaper on headline valuation multiples. TMO trades at 24.1x Forward P/E, 36.3x Trailing P/E, 2.01x PEG, and 6.1x EV/Revenue (16.0% FCF margin), whereas LZAGY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TMO (13.4% ROE) versus LZAGY (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, TMO carries 40.2% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.78x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.58β · 30% Vol realized risk). By comparison, LZAGY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 17% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.